» Articles » PMID: 12810430

Clinical Value of Gallium-67 Scintigraphy in Assessment of Disease Activity in Wegener's Granulomatosis

Overview
Journal Ann Rheum Dis
Specialty Rheumatology
Date 2003 Jun 18
PMID 12810430
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Diagnosis of active pulmonary and paranasal involvement in patients with Wegener's granulomatosis (WG) can be difficult. The diagnostic value of gallium-67 scintigraphy in WG is unclear.

Objective: To evaluate the added diagnostic value of gallium-67 scintigraphy in patients with WG with suspected granulomatous inflammation in the paranasal and chest regions.

Methods: Retrospectively, the diagnostic contribution of chest and head planar gallium scans in 40 episodes of suspected vasculitis disease activity in 28 patients with WG was evaluated. Scans were grouped into normal or increased uptake for each region. Histological proof or response to treatment was the "gold standard" for the presence of WG activity.

Results: WG activity was confirmed in 8 (20%) episodes, with pulmonary locations in three, paranasal in four, and both in one (n=7 patients); all these gallium scans showed increased gallium uptake (sensitivity 100%). Gallium scans were negative for the pulmonary area in 23/36 scans (specificity 64%), and negative for paranasal activity in 13/16 scans (specificity 81%) in episodes without WG activity. Positive predictive value of WG activity for lungs and paranasal region was 24% and 63%, respectively, negative predictive value was 100% for both regions. False positive findings were caused by bacterial or viral infections.

Conclusion: Gallium scans are clinically helpful as a negative scan virtually excludes active WG. Gallium scintigraphy of chest and nasal region has a high sensitivity for the detection of disease activity in WG. However, because of positive scans in cases of bacterial or viral infections, specificity was lower.

Citing Articles

Positron emission tomography scanning in anti-neutrophil cytoplasmic antibodies-associated vasculitis.

Kemna M, Vandergheynst F, Voo S, Blocklet D, Nguyen T, Timmermans S Medicine (Baltimore). 2015; 94(20):e747.

PMID: 25997040 PMC: 4602883. DOI: 10.1097/MD.0000000000000747.


Evaluation of Wegener's granulomatosis using 18F-fluorodeoxyglucose positron emission tomography/computed tomography.

Ito K, Minamimoto R, Yamashita H, Yoshida S, Morooka M, Okasaki M Ann Nucl Med. 2012; 27(3):209-16.

PMID: 23242952 PMC: 3618408. DOI: 10.1007/s12149-012-0675-3.

References
1.
Girard T, Mahr A, Noel L, Cordier J, Lesavre P, Andre M . Are antineutrophil cytoplasmic antibodies a marker predictive of relapse in Wegener's granulomatosis? A prospective study. Rheumatology (Oxford). 2001; 40(2):147-51. DOI: 10.1093/rheumatology/40.2.147. View

2.
Jennette J, Falk R . Small-vessel vasculitis. N Engl J Med. 1997; 337(21):1512-23. DOI: 10.1056/NEJM199711203372106. View

3.
ALPERT L . Pulmonary uptake of gallium-67 in Wegener's granulomatosis. Clin Nucl Med. 1980; 5(2):53-4. DOI: 10.1097/00003072-198002000-00004. View

4.
Yuasa K, Tokitsu M, Goto H, Kato H, Shimada K . Wegener's granulomatosis: diagnosis by transbronchial lung biopsy, evaluation by gallium scintigraphy and treatment with sulfamethoxazole/trimethoprim. Am J Med. 1988; 84(2):371-2. DOI: 10.1016/0002-9343(88)90450-0. View

5.
Devaney K, Travis W, Hoffman G, Leavitt R, Lebovics R, Fauci A . Interpretation of head and neck biopsies in Wegener's granulomatosis. A pathologic study of 126 biopsies in 70 patients. Am J Surg Pathol. 1990; 14(6):555-64. DOI: 10.1097/00000478-199006000-00006. View